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Respected Chairperson, distinguished 
guests, members of the Indian Psychiatric 
Society, ladies and gentlemen. It is a matter of 
great privilege and honour for me to deliver the 
Tilak Venkoba Rao Oration on the occasion of 
ANCIPS2000. lam highly grateful to the Indian 
Psychiatric Society for bestowing me with this 
honour. As you know, this oration was instituted 
by Prof. A. Venkoba Rao and Prof. Parvathi Devi 
in the memory of their beloved son Tilak Venkoba 
Rao who lost his life in prime youth. I pay my 
humble respect to late Tilak. I would also like to 
pay my respect to my teachers, Prof. VK. Varma, 
Prof. P. Kulhara and Prof. Savita Malhotra, from 
whom I learnt psychiatry and basic principles of 
research. I am grateful to my earlier colleagues, 
Dr. M.S. Bhatia and Dr. Sabita Shome, who were 
also involved in my research on somatisation. I 
would also like to express my gratitude to the 
late Prof. Z.J. Lipowski, whose review paper on 
somatisation in Nov., 1988 issue of American 
Journal of Psychiatry initiated my interest in 
somatisation, the topic I have chosen for this 
oration. 
Patients presenting with physical 
symptoms without any organic basis have always 
remained an enigma for the physicians. These 
patients have been recognised for more than two 
millennia. The illnesses have received a wide 
variety of names like hysterike pnix by Plato in 
427 BC, hysterika given by Galen in the second 
century AD, English malady by Cheynes in 1789, 
neurasthenia by Beard in 1868, conversion 
hysteria, hypochondriasis, psychosomatosis, etc. 
The term 'somatisation', which was introduced 
by Stekel in 1911 for the illness, has become 
quite popular in the last two decades, especially 
after the formal recognition of somatisation 
disorder as a diagnostic entity by DSM-III in 
1980. Somatisation can be defined as a tendency 
to experience and communicate somatic distress 
and symptoms in response to psychosocial 
stress, unaccounted for by pathological findings, 
to attribute them to physical illness, and to seek 
medical help for them (Lipowski, 1988). 
Somatisation is neither a discrete clinical 
entity, nor the result of a single pathological or 
psychological process, and cuts across 
diagnostic boundaries (Kellner,1994). It is not an 
equivalent of somatisation disorder or 
somatoform disorders. The patients usually 
present in primary care settings and to physicians 
in general hospitals. They are often misdiagnosed 
and wrongly treated as suffering from physical 
illnesses. The phenomenon is responsible for 
significant distress and disability in the sufferers. 
It is estimated that a large pan of physicians' time 
and effort is spent on investigating and treating 
somatising patients and between 10-20% of the 
medical budget is spent on patients who somatise 
or have hypochondriacal concerns (Ford, 1983; 
Kellner,1991). 
In this oration, I shali be discussing about 
evolution of the concept of somatisation. clinical 
presentation of somatisation, related nosological 
issues and biological research in somatisation. 
EVOLUTION OF THE CONCEPT 
Stekel (1943), who introduced the term 
'somatisation' in scientific literature, described 
it as the process by which neurotic conflicts may 
present themselves as a physical disorder. 
Meninger (1947) described 'somatisation 
reactions' as the visceral expression of anxiety 
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that may in this way stay unconscious. Thus, 
initially the term originated in psychoanalytic 
frame of reference. Different dynamic 
explanations continued to be given by different 
workers in the next twenty years. In 1955, Schur 
explained it in terms of ego regression, which 
by primary process thinking may result in the 
ego's incapacity to neutralize aggression, and 
in turn leads to resomatisation of responses. 
Kaufman described it as regressed libidinizatron 
of an organ or organ system or fantasy of function 
of an organ system manifesting in symptoms or 
signs of somatisation. Rubins defined the 
process of somatisation as the 'psychological 
mechanisms through which the various 
personality elements, the idealization and 
rejection of attitudes and self-aspects, and body-
image distortions get translated into somatic 
symptoms' (van der Feltz-Cornelis and van 
Dyek,1997). 
In contemporary psychiatry, somatisation 
is described more in clinical terms without going 
into a hypothetical actiological explanation. No 
presumptions are made about its having a 
biological or psychological basis. Katon et al. 
(1984) describe it as an idiom of distress in which 
patients with psychosocial and emotional 
problems articulate their distress primarily 
through physical symptomatology It is an 
expression of personal and social distress in an 
idiom of bodily complaints with medical help 
seeking (Kleinman & Kleinman,1986). Lipowski's 
definition as given earlier is also somewhat 
similar.the term 'medically unexplained 
symptoms' has also been suggested as a 
substitute (Mayou,1993), but this has less 
theoretical implications than the term 
somatisation (van der Feltz-Cornelis & van Dyek, 
1997). It needs to be emphasised here that 
somatisation should not be taken as a diagnosis, 
because this would limit attempts to reach a more 
complete understanding of the etiology and 
prognosis (Stewart, 1992; Sensky,1994). 
It may be argued that somatisation is a 
residual category covering symptoms that can't 
be ascribed solely to the body, as in the case of 
neurasthenia or solely to the mind. The model 
behind somatisation is that the mind influences 
the body. A link between biological and 
psychological symptoms is presumed without 
having specific knowledge about the nature of 
these influences (van der Feltz-carnelis and van 
Dyek, 1997). Somatisation can occur in a diversity 
of psychiatric disturbances, but may also exist 
independently as a transient phenomenon. It both 
involves cognition and behaviour, but may be 
considered a fallout product of the conceptual 
gap between body and mind in the contemporary 
conceptualisation of disease. 
CLINICAL PRESENTATION OF SOMATISATION 
Somatisation symptoms can involve any 
body area or system. Pain involving different 
body parts, cardiopulmonary, gastrointestinal and 
neurological symptoms can occur alone or in 
different combinations (Lipowski,1988; 
Srinivasan et al.,1986). In our study, subjective 
weakness, headache, vague somatic sensations, 
pain in extremities and palpitations were the five 
commonest symptoms reported by somatising 
patients. Symptoms of subjective weakness, 
headache, pain in extremities and 
pseudoseizures were more common in female 
patients than in males, whereas palpitations were 
more common in mate patients compared to 
females (Chadda et al.,1991). Somatisation 
presents in three overlapping, though 
conceptually distinct, patterns of behaviour. 
These include high levels of medically 
unexplained symptoms referring to multiple 
physiological systems; somatic preoccupation 
or illness worry beyond what is expected for 
demonstrable physical disease as in 
hypochondriasis, and; the predominatly or 
exclusively somatic clinical presentation of 
psychiatric illnesses like depression, anxiety, etc. 
(KirmayerS Robbins,1991). All these forms, are 
quite common in clinical practice, both 
independently as well as in co-existing situations. 
The first form of somatisation is the 
medically unexplained symptoms. An 
emotionally distressed person may selectively 
present physical complaints to a doctor on the 
assumption that this is the best approach to 
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secure relief for the psychological distress. A. 
careful interview is likely to reveal the underlying 
psychosocial distress. To-operationalise the 
phenomenon, Bridges and Goldberg (1985) have 
given two criteria for somatisation; oae must 
attribute the symptoms to physical illness, and ; 
one must report, when properly interviewed, 
symptoms that justify psychiatric diagnosis. The 
physical symptoms may belong to different 
bodily systems, occurring in different 
combinations. Somatisation disorder is an 
extreme form of this kind of presentation 
(American Psychiatric Association, 1994). The 
disorder as defined in DSM-III, DSM-III-R, DSM-
IV or ICD-10 is relatively rare. The multicentric-
NIMH Epidemiological Catchment Area (ECA) 
study showed a prevalence of 0-0.7% across 
different sites (Escobar et al., 1987; Swartz ef 
al., 1986). WHO'S multicentric study done in 15 
centres in 14 countries, found a prevalence of 
2.8% of somatisation disorder as defined by ICD-
10 and of 0.9% when DSM-III-R definition was 
used (Gureje etal., 1997). Considering the rarity 
of somatisation disorder and commonness of 
somatisation phenomenon, Escobar and Canino 
(1989) suggested abridged criteria of four 
unexplained symptoms for men and six for 
women to define a sub-syndromal somatisation 
drsorder or somatic symptom index. This 
disorder had a community prevalence of 9 - 20% 
in ECA samples. Use of similar concept found 
a prevalence of 19.7% across different sites in 
the WHO'S multinational stbdy (Gureje et aL, 
1997). The concept of somaiic symptom index 
or abridged somatisation gets further validation 
frorrr the findings that these patients show high 
utilisation of mental health and medical services 
and disability (Escobar, 1987; Escobar & Canino, 
1989). In WHO'S multicentric study, symptoms 
showed a modest association with low education., 
The rates were much higher in South American 
sites. However, frequency of unexplained 
somatic symptoms did not clearly vary according 
to geography or level of economic development. 
Somatising patients were at elevated risk for self-
reported disease burden, negative perception oi 
their health, and comorbid depression and 
generalised anxiety disorder. Somatisation was 
commonly associated with disability. Cultures did 
not differ markedly in the pattern of these 
associated features (Gureje et al.,1997; Gureje 
& Simon, 1999). In a study by the author, patients 
presenting with abridged somatisation alongwith 
depression showed more psychosocial 
dysfunction than the somatising patients without 
a depressive diagnosis (Chadda et al., 1993). The 
dysfunction was seen in different areas of 
psychosocial functioning like personal, social, 
vocational and familial areas, but was minimal 
in cognitive sphere. 
The second concept of somatisation, 
somatic preoccupation or hypochondriacal worry, 
developed out of the study of clinical illness 
behaviour (Pilowsky,1990). Probably an 
amplifying.somatic style leads to experience and 
expression of high levels of somatic distress in 
response to mild disturbances or even normal 
physiological processes (Barsky & Klerman, 
1983; Barsky & Wyshak,1990; Barsky,1992). 
The prevalence of hypochondriacal concerns in 
clinical and non-clinical samples ranges from 3 
to 13% (Barsky et al.,1986; Kellner,1991). In 
hypochondriasis, the symptoms or level of 
distress experienced by patients is unexplained 
by physical disease and symptoms are not 
usually multiple in nature. 
The third definition of somatisation," the 
somatic clinical presentation of psychiatric 
disorders other than somatoform disorders, has 
been studied primarily by consultation-liaison 
psychiatrists in primary care and speciality 
medical settings. Depression and anxiety 
disorders have been reported to have a 
combined prevalence of 10-20% in primary care 
population (Barrett et al.,1988). More than 50% 
of these patients make somatised or masked 
clinical presentations (Katon et a!., 1984). A 
similar study by Bridges and Goldberg (1985) 
found that 56% of primary care patients with 
psychiatric disorders had somatised 
presentation, 17% had psychological symptoms 
and the remaining 27% had a concomitant 
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physical disease. In a study on somatisation in 
psychiatric patients in India, 81.9% of patients 
presented with somatic symptoms. This included 
97.8% of patients with depression, 85.8% of 
patients with anxiety neurosis, all cases of 
hysterical neurosis, 6.7% of schizophrenia 
patients and 11.1% of patients with mania 
(Chadda& Bhatia, 1990) 
There is a frequent co-occurrence of the 
three forms of somatisation. Major depression 
and anxiety disorders are common among 
patients with medically unexplained symptoms 
(Lipowski,1990; Chadda & Bhatia, 1990) More 
than 60% of people with full or subsyndromal 
somatisation disorder have a past history of 
some other psychiatric disorder, mostly major 
depression or anxiety disorder (Escobar & 
Canino,1989). Hypochondriacal patients tend 
to report high levels of current somatic 
symptoms. However, the prevalence of 
somatisation disorder in hypochondriacal 
patients has not been reported (Kellner,1994). 
Similarly, the prevalence of hypochondriacal 
beliefs in somatisation disorder is not known 
(Kellner,1991). Increased levels of 
hypochondriacal worry have been reported in 
patients with chronic idiopathic benign pain and 
other medically unexplained symptoms. 
Hypochondriacal fears are also found in 25 to 
33% of patients with depression (Hamilton,1989). 
Almost all patients with major depression or 
anxiety disorders have somatic complaints that 
include pain or other vegetative symptoms 
(Katon et al.,1984; Chadda & Bhatia, 1990; 
Srinivasan et al.,1986; Nelson & Charney, 1981). 
Patients with diagnosis of hypochondriasis have 
often elevated levels of depressive and anxiety 
symptoms, not fulfilling criteria for a coexisting 
major affective disorder (Kellner 1991). 
Nosological issues 
Somatisation may occur as a transient 
stress response or may be persistent. The 
former would hardly warrant a psychiatric 
diagnostic label. Persistant somatisation is a 
matter of great concern and cuts across different 
diagnostic entities, as also stated earlier. 
Somatisation may occur as a primary 
disturbance, as in somatoform disorders; or in 
association with other psychiatric disorders, such 
as major depression or anxiety disorders 
(Escobar, 1987). 
Psychiatric diagnoses in somatising 
patients include depressive and anxiety disorders 
with secondary somatisation or somatoform 
disorders where somatisation is the primary 
phenomenon (Lipowski,1988; Chadda et al., 
1991). The category of somatoform disorders is 
a relatively recent diagnostic category introduced 
by DSM-III in 1980 and also included by ICD 10 
in 1992. Nosological issues related to 
somatisation can be discussed in relation to 
occurrence of the phenomenon in somatoform 
disorders, depression, anxiety disorders and 
psychotic disorders. 
Somatisation and somatoform disorders 
Inclusion of the category of somatoform 
disorders by DSM-III in 1980 was a major step 
in recognising the importance of the 
phenomenon of somatisation. This helped in * 
bringing together a group of disorders known 
since long by different names as distinct 
diagnostic entities into a more discrete category. 
However, except for somatisation disorder which 
had been extensively studied for diagnostic 
stability and validity (Perley & Guze,1962; Guze, 
1970; Cloninger et al.,1975; Gordon et al.,1986 
a,b), the other somatoform diagnoses are just 
non-specific symptom clusters, that can not be 
properly operationalised and rarely occur in pure 
forms. Each of these disorders has arisen in a 
different school of psychiatric thought. The 
concept of conversion disorder is basically a 
psychodynamic one, whereas somatization 
disorder is a result of phenomenological and 
descriptive research. The pain disorder has 
achieved recognition primarily because of its 
clinical significance (Chadda, 1993, 1999). 
Out of the various somatoform disorders, 
conversion disorder and hypochondriasis were 
traditionally grouped under neuroses, whereas 
somatization disorder was considered a type or 
variant of hysteria. Psychogenic pain disorder 
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(pain disorder in DSM-IV) has also gained a 
honorable position, as earlier it was put in 
miscellaneous group in various classification 
systems. DSM-III-R and DSM-IV have also 
included the categories of undifferentiated 
somatoform disorder and body dysmorphic 
disorder in an attempt to be more specific. ICD-
10 differs from DSM-IV in not including the 
categories of conversion disorder in somatoform 
disorders. Another important diagnosis, 
neurasthenia (chronic fatigue syndrome) does 
not find place in somatoform disorders, though 
its presentation is predominantly somatic 
(Chadda,1999). 
Similarly, in case of certain culture bound 
syndromes like Koro and Dhat syndrome, the 
presentation is predominantly somatic, and 
therefore there is a cause to include these under 
somatoform disorders (Chadda & Ahuja,1990; 
Chadda & Shome,1991; Chadda,1995; 
Chaudhary,1992). Some beginning has been 
made in this direction in ICD-10 by including such 
disorders under other unspecified neurotic 
disorders. The duration criteria of 6 months for 
pain disorder and undifferentiated somatoform 
disorder in DSM-IV result in too many not 
otherwise specified (NOS) diagnoses in clinical 
practice. In our study on diagnostic uncertainties 
in somatising patients, 39% of patients received 
NOS diagnoses on DSM-III-R. Such duration 
criteria are of more utility in the research settings 
rather than in clinical practice (Chadda et al., 
1991; Chadda,1992). 
Somatisation and depressive disorders 
Depression is one of the most common 
causes of somatisation (Katon et al.,1984). A 
majority of the patients presenting with 
depressive disorders in primary care settings do 
so for somatic rather than psychological distress 
and symptoms (Bridges & Goldberg,1985). 
Depressed patients in psychiattic settings also 
show high prevalence of somatic symptoms 
(Chadda & Bhatia,1990). Some depressed 
patients are convinced that their physical 
symptoms are due to somatic illness and may 
deny being emotionally distressed, while the 
majority seem to be aware of both bodily and 
affective distress but are unsure which of them 
is primary (Katon et al., 1984). Most of these 
patients, however, seek help from non-
psychiatric physicians for somatic symptoms. If 
one accepts the notion of somatisation trait, then 
those possessing it will tend to report primarily 
physical symptoms when depressed. Others may 
choose to present such symptoms not because 
they do not experience depressed mood but 
because they do not wish to be given psychiatric 
diagnosis and hence be stigmatised or because 
they believe it inappropriate to discuss about 
psychosocial issues with general practitioners 
(Lipowski,1988). 
Somatising depressed patients may 
complain of multiple and vague somatic 
symptoms and often express related 
hypochondriacal concerns (Katon et al.,1984; 
Chadda et al.,1991). Pain is also a common 
symptom in depression. Prevalence of 
depressive disorders in patients with chronic pain 
ranges from 30%-50% (Fishbain et al.,1986). 
The arguments that depression is the cause of 
pain, and the pain is the cause of depression 
are equally plausible (Lipowski,1988). 
Somatisation and anxiety disorders 
Anxiety disorders are frequently 
associated with depression, somatisation and 
hypochondriasis (Katon et al.,1984; Wilson et 
al., 1987). Patients with panic disorder and 
generalised anxiety disorder commonly present 
with various somatic complaints, such as chest 
pain, palpitations, dyspepsia, headache, 
dizziness, fainting and dyspnea Preoccupation 
with the fear or belief of being physically ill is so 
common in some panic disorder patients that 
hypochondriasis has also been suggested as its 
essential feature by some investigators. Patients 
with panic disorder who are diagnosed early and 
treated properly tend to give up their tendency 
to somatise earlier than the depressed patients 
whose tendency to somatise and utilise health 
care is more persistent (Wilson et al.,1987). 
Somatisation and psychosis 
Somatic or hypochondriacal delusions of 
229 R.K. CHADDA 
having a physical disease or of a body change, 
malfunction or deformity may be seen in 
psychotic depression, schizophrenia and 
delusional disorders. These delusions may be 
regarded as the most pathological form of 
somatisation A psychotic patient may seek 
medical help for somatic symptoms, such as pain 
or weakness, lacking organic explanation but 
elaborated in decisional manner. 
Biological basis of somatisation 
The concept of somatisation arose from 
psychoanalytic school of thought. As earlier 
discussed, it cuts across different psychiatric 
diagnoses and seen as a part of clinical 
presentation of anxiety, depressive and 
somatoform disorders. Biological basis of 
somatisation is still not clear and different 
hypotheses have been given, based on some 
experimental findings in different psychiatric 
disorders in which the phenomenon has been 
reported There is some evidence though not 
conclusive about biological abnormalities or 
genetic factors associated with somatisation and 
somatoform disorders. Besides genetic factors, 
other investigations have been done in 
neurophysiological parameters, neurotransmitters 
and neuropsychological functions like cognition 
and perception. Figure gives a diagrammatic 
representation of various etiological factors 
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operating in the genesis of somatisation. 
Role of genetic factors is mainly established 
in somatisation disorder. Antisocial personality 
disorder and somatisation disorder may have a 
common genetic background. Somatisation 
disorder may be the female expression of a genetic 
tendency with antisocial personality disorder being 
its male counterpart (Guggenheim & Smith, 1995). 
Familial basis is established in Briquet's syndrome, 
of which the somatisation disorder can be easily 
called a descendent. Briquet's syndrome is seen 
in 10-20% of the female first degree relatives of 
probands with the syndrome which is a fivefold to 
tenfold increase over the lifetime risk of the 
disorder in women in the general (Clonmger, 1994; 
Cloninger et at.,1975). The male relatives of 
women with Briquet's syndrome show an increased 
risk of antisocial personality and alcoholism 
(Cloninger etal,1975). However, men with many 
somatic complaints are probably heterogeneous 
and don't aggregate in families with male or female 
somatisers (Cloningeret al.,1984). Somatisation 
in women has a common etiology with antisocial 
personality, but not with somatisation in man 
(Clonmger, 1994). The familial aggregation could 
be due to genetic factors, environmental factors 
or the both, as shown by an adoption study of 
somatoform disorders from Sweden (Bohman et 
al.,1984). Using comprehensive lifetime medical 
records in Sweden, Cloninger et al. (1984) 
distinguished two discrete kinds of somatoform 
disorders in women: high frequency somatisation-
(complaints of headache, backache, 
gastrointestinal and gynaecological complaints 
with psychiatric disability, and the other group, 
diversiform somatisers, characterised by diverse 
but fewer complaints and less frequent disability). 
Women who were adopted away at an early age 
had a fivefold increase in. high freq-uency 
somatisation disorder if their biological parents 
were antisocial or alcoholic (Cloninger et at, 1984; 
Cloninger,1994). 
Studies of biological and adoptive parents 
of hyperactive children have provided evidence 
of sharing of genetic factors between Briquet's 
syndrome and attention deficit disorder with 
hyperactivity in children. Briquet's syndrome and 
antisocial personality are increased in the biofogic 
parents of hyperactive children in intact families 
but not in adoptive parents (Cloninger,1994). 
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There is also some evidence from twin 
studies towards role of genetic factors in etiology 
of somatisation. A MMPI study of MZ and t)Z 
adolescent twins favoured only a smart 
contribution of genetics to somatic symptoms 
formation (Gottesman, 1962). Another twin study 
from general population using self rating scales 
suggested role of genetic factors in somatic 
anxiety (Kendler et al., 1987). One small twin 
study of somatoform disorders which included 
35 twins of different categories of somatoform 
disorders, found 29% concordance in MZ twins 
and 10% in DZ pairs. The differences were not 
statistically significant. Anxiety disorders 
especially generalized anxiety disorder were also 
common in co-twins of probands with 
somatoform disorders. The results can't be said 
conclusive since sample size was quite small 
(Torgersen,1986). 
Neurophysiological abnormalities in 
evoked- potentials have been found in patients 
with somatisation disorder and conversion 
disorder. Similarly, abnormalities in information 
processing have been hypothesised in various 
somatoform disorders. 
Some abnormalities in information 
processing system have also been reported, like 
distractibility, difficulty in differentiating between 
target and non-target stimuli, and impaired verbal 
communication. This leads to inability to 
habituate to repetitive stimuli (Flor-Henry et al., 
1981; James etal.,1990). The distractibility and 
impaired differentiating ability leads to vague 
nonspecific labels for various experiences, and 
unclear and incomplete statements of ideas and 
feelings, and distortion of new information to fit 
earlier preconceptions. Selective attention also 
increases the perception of somatic sensations. 
Flor-Henry et al.(1981) found that Briquet 
syndrome patients, when compared with normal 
controls, have a bilateral and symmetrical 
pattern of frontal lobe impairment. They also 
have bilateral, but principally non-dominant (right 
sided) posterior temporal deficits. 
Evoked potential studies have reported 
large N1 amplitudes in somatization disorder 
patients, suggesting a disturbed capacity to filter 
out trivial afferent stimuli (Gordon et al.,1986 a, 
b). Similarly, increased P1 N1 amplitude change 
as a function of stimulus intensity inpatients with 
somatization disorder suggest an enhanced CNS 
response to sensory input (James et al.,1990). 
Mismatch negativity (MMN), another EP 
parameter has been reported to be smaller, 
suggesting that somatizers probably respond 
more similarly than the normals to relevant and 
irrelevant stimuli (James et al.,1989). Loss of 
stimulus discrimination, self regulation and 
cognitive integration of experience appear to be 
in background of tendency to somatize (van der 
Feltz-Cornelis and van Dyek, 1997). 
Patients with conversion disorders suffer 
from excessive cortical arousal, which causes 
reactive inhibition of signals at synapses in 
sensory-motor pathways by way of negative 
feedback relationship between cerebral cortex 
and the brainstem reticular formation. This 
explains the diminished awareness of bodily 
sensations in some conversion disorder patients 
(Behrman & Levy, 1970). This aJso explains the 
precipitation of symptoms by stress, reduction 
of anxiety following appearance of symptoms 
and effectiveness of amobarbital infusion and 
other sedatives in symptom remission (Raskin 
et al.,1966; Lader,1982; Frumkin et al.,1981). 
The increased susceptibility of certain 
individuals, like those with histrionic, dependent 
or antisocial personality traits, and cithers has 
also been explained on neurophysiological basis. 
Probably, some of them have low- sedation 
threshold, dominant cerebral hemisphere 
dysfunction or have suffered from frontal lobe 
trauma or impairment (Flor-Henry et al.,1981). 
Most patients of conversion disorder have 
bilateral symptoms. But when the symptoms are 
unilateral, left side is usually affected. This 
phenomenon is more common in women and is 
probably a direct consequence of brain neural 
organization (Flor-Henry etal.,1981; Min & Lee, 
1997; Merskey & Watson, 1979). 
Hypochondriasis is the result of an 
underlying perceptual or cognitive abnormality. 
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The patients amplify and augment normal bodily 
sensations and perceive them as more noxious 
and intense than does the person who is not 
hypochondriacal. They have constitutionally 
lower threshold and tolerance for physical 
discomfort (Barsky, 1977; Robbinsand Kirmayer, 
1996; Mayou,1976). They misinterpret normal 
bodily sensations, physiological functions, the 
trivial symptoms of every day life and the 
somatic symptoms of emotional arousal by 
misattributing them to a serious disease process. 
Recently, it has been reported that, though the 
hypochondriacal patients are more sensitive to 
normal physiological sensations and minor bodily 
parameters than the non-hypochondriacs, 
objective parameters like ability to discriminate 
between two factual bodily signals don't confirm 
it (Barsky & Wyshak,1990; Haenen et al.,1997; 
Barsky,1992). They are also probably 
constitutionally predisposed to thinking and 
perceiving in concrete and physical terms rather 
than in emotional and subjective terms (Barsky 
& Wyshak,1990). 
Abnormalities in neurotransmitters have 
specifically been seen in pain disorders. 
Serotonin has been reported to have an inhibiting 
effect on pain perception and has been 
implicated in pain disorder. Endorphins and 
serotonin metabolites are decreased in 
cerebrospinal fluid of chronic pain patients (von 
Knorring et al., 1979). 
Substance P, another neurotransmitter, is 
also involved in altering the pain threshold. 
Patients with somatoform pain syndromes have 
higher autonomic and muscle activity as 
compared to controls. There is dysfunction of 
corticofugal inhibitory system resulting in 
insufficient inhibition of the afferent stimulation, 
which results in amplification or heightened 
arousal to somatic sensory input. 
Somatisation in depressive disorders may 
have different origins. Some of the physical 
complaints are vegetative symptoms 
concomitant with depressed mood, while others 
are somatic metaphors with which patients 
communicate their emotional distress. The 
depressed mood may also influence cognition 
in the direction of augmented perception of bodily 
sensations and their interpretation in terms of 
physical illness. Some investigators suggest that 
somatic complaints constitute a major feature 
of depression and should be included among its 
diagnostic criteria (Wilson et al.,1987). 
Somatisation in anxiety disorders patients 
has been attributed to enhanced awareness of 
ana selective attention to bodily sensations and 
danger related information, increased 
sympathetic nervous system arousal, and a 
negative bias in appraising one's health (Noyes 
et al.,1986; Macleod et al.,1986). 
In conclusion, somatisation appears a 
complex phenomenon, quite common in clinical 
practice, occurring in a wide range of disorders. 
A critical analysis of the phenomenon has led 
to identification of the new diagnosis group of 
somatoform disorders. Certain 
neurophysiological abnormalities have been 
identified in somatisation disorder, conversion 
disorder, hypochondriasis and somatoform pain 
disorder. Evidence of genetic basis in causation 
of some of these disorders has also emerged. 
The phenomenon is an interesting example 
in psychiatry in recent years, where creation of 
new diagnosis groups on the basis of an empirical 
phenomenon may probably lead to understanding 
the biological basis of these groups of disorders, 
a field where earlier biological research had not 
led to any conclusive findings. 
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